Brett Sandercock Resmed Inc (RSMDF) insider trading activity

Brett Sandercock is Chief Financial Officer of RESMED INC. Currently has a direct ownership of 90,056 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Dec 10, 2021, when has been sold 2,500 shares (ResMed Common Stock) at a price of $264.92 per share, resulting in proceeds of $662,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.1K

3.13% 3M change

0.97% 12M change

Total Value Held $0

Brett Sandercock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2021	SELL Open market or private sale	$662,300 $264.92 p/Share	2,500 Reduced 2.3%	106,354 ResMed Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.25%	108,854 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	1,161 Added 1.08%	106,354 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$5,187,932 $254.81 p/Share	20,360 Added 16.22%	105,193 ResMed Common Stock
Nov 10 2021	SELL Open market or private sale	$651,450 $260.58 p/Share	2,500 Reduced 2.86%	84,833 ResMed Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.78%	87,333 ResMed Common Stock
Oct 11 2021	SELL Open market or private sale	$1,266,850 $253.37 p/Share	5,000 Reduced 5.57%	84,786 ResMed Common Stock

Oct 11 2021	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.71%	89,786 ResMed Common Stock
Sep 10 2021	SELL Open market or private sale	$1,486,650 $297.33 p/Share	5,000 Reduced 5.42%	87,286 ResMed Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.64%	92,286 ResMed Common Stock
Aug 20 2021	SELL Open market or private sale	$3,024,653 $281.73 p/Share	10,736 Reduced 10.68%	89,786 ResMed Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	$620,111 $57.76 p/Share	10,736 Added 9.65%	100,522 ResMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	4,784 Added 5.06%	89,786 ResMed Common Stock
Aug 10 2021	SELL Open market or private sale	$695,125 $278.05 p/Share	2,500 Reduced 2.86%	85,002 ResMed Common Stock
Jul 12 2021	SELL Open market or private sale	$621,150 $248.46 p/Share	2,500 Reduced 2.78%	87,502 ResMed Common Stock
Jun 10 2021	SELL Open market or private sale	$532,100 $212.84 p/Share	2,500 Reduced 2.7%	90,002 ResMed Common Stock
May 10 2021	SELL Open market or private sale	$490,000 $196.0 p/Share	2,500 Reduced 2.63%	92,502 ResMed Common Stock
Apr 12 2021	SELL Open market or private sale	$496,175 $198.47 p/Share	2,500 Reduced 2.57%	94,922 ResMed Common Stock
Mar 10 2021	SELL Open market or private sale	$462,500 $185.0 p/Share	2,500 Reduced 2.5%	97,422 ResMed Common Stock
Feb 10 2021	SELL Open market or private sale	$503,425 $201.37 p/Share	2,500 Reduced 2.44%	99,922 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	1,822 Added 1.75%	102,422 ResMed Common Stock
Jan 11 2021	SELL Open market or private sale	$546,750 $218.7 p/Share	2,500 Reduced 2.42%	100,600 ResMed Common Stock
Dec 10 2020	SELL Open market or private sale	$527,650 $211.06 p/Share	2,500 Reduced 2.37%	103,100 ResMed Common Stock
Nov 24 2020	SELL Open market or private sale	$1,055,000 $211.0 p/Share	5,000 Reduced 4.52%	105,600 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$5,636,066 $214.74 p/Share	26,246 Added 19.18%	110,600 ResMed Common Stock

Brett Sandercock

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account